Description
A standardized polyphenolic extract from Echinacea species (typically Echinacea purpurea or Echinacea angustifolia), characterized by cichoric acid and caftaric acid content. Distinct from the full-spectrum Echinacea purpurea extract (catalog id 8790) which preserves the alkamide fraction, this grade targets the polyphenol fingerprint for analytical specification and clinical-format formulations.
Yellow-brown to dark brown free-flowing powder. Highly water-soluble.
We supply food-grade Echinacea Polyphenol from manufacturers in China holding ISO, Halal, Kosher and other certifications relevant to the product and production.
Common market grades include 1 percent Cichoric Acid (standard supplement grade), 2 percent Cichoric Acid (the EP-aligned premium grade), 4 percent Total Polyphenols (broader fingerprint grade), and 8 percent Total Polyphenols (high-end concentrated grade).
Bulk and reduced-MOQ shipments. Batch-level COA covering cichoric acid (HPLC), caftaric acid (HPLC), total polyphenols (UV), residual solvents, heavy metals, pesticides, and microbiology.
Introduction
Echinacea was used by indigenous North American peoples for wound healing, snake bites, and respiratory infections. European phytotherapy adopted echinacea in the early 20th century, and standardized preparations are now among the most commercially significant herbal medicines worldwide for cold and immune-support applications.
Industrial production proceeds by hydroalcoholic extraction of the aerial parts or roots of Echinacea species, followed by purification and standardization to defined cichoric acid or total-polyphenol content. The polyphenol-standardized fraction is preferred for water-based and analytical-specification applications, while the alkamide-rich full-spectrum extract is preferred for traditional immune-support positioning.
Listed in EP, USP, and several national pharmacopoeias as a pharmaceutical product. Recognized as a permitted food ingredient by the U.S. FDA (GRAS) and the European Food Safety Authority.
Clinical evidence for echinacea is mixed but supports modest reductions in cold incidence and duration when standardized preparations are used at appropriate doses. The compound class is among the most extensively studied herbal medicines in controlled clinical trials.
Strategic positioning is dominated by cold-and-flu prevention supplements, with established European phytopharmaceutical channels and growing functional-beverage applications.
Where it is used
- Immune-support dietary supplements: cold and flu prevention positioning (the dominant commercial application)
- Pharmaceutical-format echinacea preparations in the European phytopharmaceutical channel
- Cold-and-cough lozenges and chewable formats
- Functional beverages: immune-shot and wellness-drink applications
- Pediatric immune-support formulations (in markets where echinacea is approved for children)
- Cosmetic skincare: anti-inflammatory and skin-soothing topical actives
- Veterinary immune-support formulations
Technical data
| Item | Specification |
|---|---|
| Appearance | Yellow-brown to dark brown free-flowing powder |
| Cichoric acid (HPLC) | 1% / 2% (grade dependent) |
| Total polyphenols (UV) | 4% / 8% (grade dependent) |
| Caftaric acid (HPLC) | ≥ 0.5% |
| Loss on drying | ≤ 5.0% |
| Heavy metals (as Pb) | ≤ 2 mg/kg |
| Total plate count | ≤ 1000 cfu/g |
| Source | Echinacea purpurea or E. angustifolia aerial parts and roots |
Ready to discuss business?
Send us your spec and requirement. We will respond with availability and pricing within 24 hours.